More IDO Issues: NewLink Drops Pancreatic Cancer Indication For Indoximod

 
• By Lucie Ellis-Taitt
  
Juggling
NewLink juggles too many indoximod options; drops pancreatic cancer program • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Immuno-oncology

More from Anticancer